Cargando…

Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis

Detalles Bibliográficos
Autores principales: Schmierer, Klaus, Wiendl, Heinz, Oreja-Guevara, Celia, Centonze, Diego, Chudecka, Anita, Roy, Sanjeev, Boschert, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574232/
https://www.ncbi.nlm.nih.gov/pubmed/35672923
http://dx.doi.org/10.1177/13524585221099413
_version_ 1784811063037919232
author Schmierer, Klaus
Wiendl, Heinz
Oreja-Guevara, Celia
Centonze, Diego
Chudecka, Anita
Roy, Sanjeev
Boschert, Ursula
author_facet Schmierer, Klaus
Wiendl, Heinz
Oreja-Guevara, Celia
Centonze, Diego
Chudecka, Anita
Roy, Sanjeev
Boschert, Ursula
author_sort Schmierer, Klaus
collection PubMed
description
format Online
Article
Text
id pubmed-9574232
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-95742322022-10-18 Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis Schmierer, Klaus Wiendl, Heinz Oreja-Guevara, Celia Centonze, Diego Chudecka, Anita Roy, Sanjeev Boschert, Ursula Mult Scler Original Research Papers SAGE Publications 2022-06-07 2022-11 /pmc/articles/PMC9574232/ /pubmed/35672923 http://dx.doi.org/10.1177/13524585221099413 Text en © The Author(s), 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Papers
Schmierer, Klaus
Wiendl, Heinz
Oreja-Guevara, Celia
Centonze, Diego
Chudecka, Anita
Roy, Sanjeev
Boschert, Ursula
Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
title Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
title_full Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
title_fullStr Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
title_full_unstemmed Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
title_short Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
title_sort varicella zoster virus and influenza vaccine antibody titres in patients from magnify-ms who were treated with cladribine tablets for highly active relapsing multiple sclerosis
topic Original Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574232/
https://www.ncbi.nlm.nih.gov/pubmed/35672923
http://dx.doi.org/10.1177/13524585221099413
work_keys_str_mv AT schmiererklaus varicellazostervirusandinfluenzavaccineantibodytitresinpatientsfrommagnifymswhoweretreatedwithcladribinetabletsforhighlyactiverelapsingmultiplesclerosis
AT wiendlheinz varicellazostervirusandinfluenzavaccineantibodytitresinpatientsfrommagnifymswhoweretreatedwithcladribinetabletsforhighlyactiverelapsingmultiplesclerosis
AT orejaguevaracelia varicellazostervirusandinfluenzavaccineantibodytitresinpatientsfrommagnifymswhoweretreatedwithcladribinetabletsforhighlyactiverelapsingmultiplesclerosis
AT centonzediego varicellazostervirusandinfluenzavaccineantibodytitresinpatientsfrommagnifymswhoweretreatedwithcladribinetabletsforhighlyactiverelapsingmultiplesclerosis
AT chudeckaanita varicellazostervirusandinfluenzavaccineantibodytitresinpatientsfrommagnifymswhoweretreatedwithcladribinetabletsforhighlyactiverelapsingmultiplesclerosis
AT roysanjeev varicellazostervirusandinfluenzavaccineantibodytitresinpatientsfrommagnifymswhoweretreatedwithcladribinetabletsforhighlyactiverelapsingmultiplesclerosis
AT boschertursula varicellazostervirusandinfluenzavaccineantibodytitresinpatientsfrommagnifymswhoweretreatedwithcladribinetabletsforhighlyactiverelapsingmultiplesclerosis